| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |